GlassScriptPhysician profile
Amit H Manhas
NPI 1619142528
$5,158.29
in general payments reported to CMS, 2019-2025
35 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $426 · 2021: $637 · 2022: $800 · 2023: $556 · 2024: $723 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,869.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,316.95 | 2020-2025 | Jot Dx, Cardiomems, Agilis |
| Philips North America LLC | $725.35 | 2019-2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.61 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $333.55 | 2019-2022 | |
| Abiomed | $293.24 | 2019-2025 | Impella |
| Pfizer INC. | $253.40 | 2021-2024 | |
| Boston Scientific Corporation | $179.13 | 2019-2023 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $172.62 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $168.14 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $165.33 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $161.58 | 2021-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $147.37 | 2019 | |
| Heartflow, INC. | $104.39 | 2019-2022 | |
| Medtronic, INC. | $96.01 | 2021-2024 | In.Pact Admiral |
| Chiesi USA, INC. | $77.53 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $76.92 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $73.90 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $45.30 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $44.16 | 2024 | Inspire |
| Silk Road Medical, INC. | $42.81 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $41.95 | 2019-2020 | |
| Becton, Dickinson and Company | $24.68 | 2024 | Site-Rite |
| Kiniksa Pharmaceuticals International, Plc | $24.66 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $23.94 | 2025 | Verquvo |
| Atricure, INC. | $21.66 | 2023 | |
| Siemens Medical Solutions USA, INC. | $21.45 | 2019 | |
| Koya Medical, INC. | $20.22 | 2025 | Koya Medical, Dayspring |
| Tactile Systems Technology INC | $18.99 | 2023 | Entre Plus, Flexitouch Plus |
| Cook Medical LLC | $17.70 | 2025 | Zilver Ptx |
| Bayer Healthcare Pharmaceuticals INC. | $17.01 | 2021 | |
| Biotronik INC. | $15.79 | 2019 | |
| Cleerly, INC. | $15.74 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $12.52 | 2021 | |
| Amgen INC. | $11.26 | 2019 | |
| Cardiovascular Systems INC. | $10.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Manhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.